Rejected at 4:49 p.m. Dec, 30, 2024 ] by Ahmed7
Author: sneakymedic
Related Note: 1480564168105 3
Rationale for change

Acute lymphoblastic leukemia most often occurs in children aged 1 to 4 years. So change to "before the age of 5 years".
(Source: https://www.cancer.gov/types/leukemia/patient/child-all-treatment-pdq#:~:text=Childhood%20acute%20lymphoblastic%20leukemia%20(also,aged%201%20to%204%20years.)
The incidence of ALL among children aged 1 to 4 years is approximately fourfold greater than that for infants and for children aged 10 years and older.

Rejection reason

this note contrasts nid:1480564291439

Please resubmit with an acceptable source. Please review suggestion guidelines, specifically rule #1: https://community.ankihub.net/t/anking-step-deck-submission-guidelines/166504

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::09_Leukemias_and_Lymphomas::03_Acute_Lymphoid_Leukemia #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::12_Acute_Leukemia #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_WBC #AK_Step1_v12::#UWorld::COMLEX::24710 #AK_Step2_v12::#OME::01_Medicine::05_Hematology_Oncology::05_Leukemia #AK_Step2_v12::#Resources_by_rotation::Peds::emma #AK_Step2_v12::#Subjects::Obstetrics_&_Gynecology::03_Pediatrics::02_Genetic_Disorders::Down_Syndrome #AK_Step2_v12::#SketchyPeds::15_Genetics_&_Metabolism::01_Aneuploidies::02_Trisomy_21 #AK_Step1_v12::#Pixorize::01_Biochemistry::08_Chromosomal_Abnormalities::01_Down_Syndrome_(Trisomy_21) #AK_Step1_v12::#SketchyBiochem::05_Clinical_Genetics::04_Trisomy_Diseases::01_Down_Syndrome #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Leukemia #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::03_White_Cells::03_Acute_Leukemias #AK_Step1_v12::#B&B::11_Genetics::02_Genetic_Disorders::01_Down_Syndrome::Extra #AK_Step1_v12::#Pathoma::06_WBC::02_Acute_Leukemia #AK_Step1_v12::#Pixorize::02_Immunology::07_Leukemias_&_Lymphomas::03_Acute_Lymphocytic_Leukemia_(ALL) #PANCE::HEME::neoplasms_premalignancies_malignancies #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::04_Oncology::01_Acute_Leukemias_SOAP #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::09_Leukemias_and_Lymphomas::01_Acute_Myeloid_Leukemia #AK_Step1_v12::#Physeo::05_Biochem::04_Genetics::17_Autosomal_Trisomies #AK_Step1_v12::#AMBOSS::nWa7Nj #AK_Step1_v12::#AMBOSS::R5alPO #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step3_v12::#UWorld::5102 #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::28_Leukemias::*Leukemia::Acute_Leukemia::Acute_Lymphoblastic_Leukemia::Basics #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step2_v12::Original_decks::Dorian::im::ome::heme/onc::leukemia #AK_Step2_v12::#AMBOSS::8S0OYf #AK_Step1_v12::#Bootcamp::Genetics::07_High_yield_genetic_disorders::05_Autosomal_trisomies #AK_Step2_v12::#Resources_by_rotation::IM::ome::heme/onc::leukemia #AK_Step1_v12::#SketchyBiochem::02_Cell_Biology::01_Cell_Cycle_&_Division::04_Nondisjunction #AK_Step1_v12::#UWorld::Step::1599 #AK_Step1_v12::^Systems::HemeOnc::WBC #AK_Step2_v12::#Subjects::Hematology::03_WBC::02_Leukemia::Acute_Leukemia::Acute_Lymphoblastic_Leukemia::*Basics #AK_Step2_v12::Original_decks::Dorian::peds::emma #AK_Step1_v12::#Physeo::05_Biochem::04_Genetics::18_Autosomal_Trisomies_-_Down_Syndrome #AK_Step2_v12::!Shelf::Peds #AK_Step1_v12::#SketchyPath::10_Myeloid_&_Lymphoid::02_Lymphoid_&_Plasma_Cell_Disorders::01_Acute_Lymphoblastic_Leukemia_(ALL),_Chronic_Lymphocytic_Leukemia_(CLL),_Hairy_Cell_Leukemia_&_Adult_T-cell_Leukemia